SuperworthALX Oncology shares outstanding ALXO
Diluted shares outstanding, averaged over each quarter, from 2019.
- Latest quarter, to Jun 30, 2026
- 135.6M
- On a year earlier
- +153.8%
- more shares
ALX Oncology had 135.6M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 153.8% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 54.3M | +0% |
| FY2024 | 54.1M | +10% |
| FY2023 | 49M | +20% |
| FY2022 | 40.7M | +1% |
| FY2021 | 40.5M | +8% |
| FY2020 | 37.6M | +1106% |
| FY2019 | 3.1M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 135.6M | +154% | |
| Q1 FY26 | 104.6M | +96% | |
| Q4 FY25 | 54.3M | +0% | |
| Q3 FY25 | 53.6M | +2% | |
| Q2 FY25 | 53.4M | +3% | |
| Q1 FY25 | 53.4M | +6% | |
| Q4 FY24 | 54.1M | +10% | |
| Q3 FY24 | 52.7M | +28% | |
| Q2 FY24 | 51.8M | +27% | |
| Q1 FY24 | 50.1M | +23% | |
| Q4 FY23 | 49M | +20% | |
| Q3 FY23 | 41.1M | +1% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on ALX Oncology
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.